Effect comparison between peginterferon α-2a and telbivudine in treatment of patients with HBeAg positive chronic hepatitis B and predictive factor for HBeAg seroconversion
-
摘要: 目的：比较聚乙二醇干扰素α-2a 与替比夫定（LDT）治疗 HBeAg 阳性慢性乙型肝炎（CHB）的疗效。方法选取HBeAg 阳性慢性乙型肝炎患者71例，分为聚乙二醇干扰素α-2a 组33例和 LDT 组38例。比较2组治疗48周的疗效，并分析HBeAg 血清学转换的相关因素。结果治疗48周时，聚乙二醇干扰素α-2a 组和 LDT 组血清 HBV DNA 转阴率分别为54．5％和78．9％（P ＜0．05），ALT复常率分别为60．6％和81．5％（P ＜0．05），HBeAg血清转换率分别为36．4％和28．9％（P ＞0．05）。2组患者在治疗48周时 HBeAg 血清转换与基线ALT、HBV DNA 水平、HBeAg 水平无显著相关性（P ＞0．05）。多因素Logistic 回归分析显示，聚乙二醇干扰素α-2a 组治疗48周时 HBeAg 血清转换率与12、36、24周时 HBeAg 下降大于2log 相关；TLD 组治疗48周时 HBeAg 血清转换率与36、24、12周时 HBeAg 下降大于2log 相关。结论 TLD 组较聚乙二醇干扰素α-2a组有更高的 HBV DNA 转阴率及 ALT 复常率。36周 HBeAg 较基线下降大于2log 可作为2组患者治疗48周时 HBeAg 血清转换的最佳预测因素。12周时 HBeAg 较基线下降大于2log 作为聚乙二醇干扰素α-2a 组治疗48周时 HBeAg 血清转换最佳预测因素，36周 HBeAg 较基线下降大于2log 作为 TLD 组治疗48周时 HBeAg 血清转换最佳预测因素。Abstract: Objective To compare the therapeutic effect between peginterferonα-2a and tel-bivudine (TLD)in treatment of patients with HBeAg positive chronic hepatitis B (CHB).Methods 71 patients with HBeAg positive CHB were divided into peginterferonα-2a group (n =33)and TLD group (n =38).Efficacy was compared and the HBeAg seroconversion factors were analyzed. Results 48 weeks after treatment,the negative conversion rates of serum HBV DNA in peginter-feronα-2a group and TLD group were 54.5% and 78.9% (P <0.05)respectively,the ALT nor-malization rates were 60.6% and 81.5% (P <0.05)respectively,the HBeAg seroconversion rates were 36.4% and 28.9% (P >0.05)respectively.There was no significant correlation between HBeAg seroconversion and ALT,HBV DNA HBeAg levels.The logistic regression analysis showed that the HBeAg seroconversion ratio in the peginterferonα-2a group at the 48th week was closely re-lated to 3 factors:the HBeAg decreased more than 2log at the 12th,24th and 36th week.The HBeAg seroconversion ratio in theTLDgroup at the4 8 thweekwas closely associatedwith 3 factors :the HBeAg decreased more than 2 log at the 3 6 th ,2 4 th and 1 2 th week .Conclusion The negative conversion rate of HBV DNA and ALT normalization rate in patients with HBeAg posi-tive CHB after 48 weeks therapy in TLD group are higher than those in peginterferonα-2a group. The HBeAg decreased more than 2log from the baseline to the 36th week can be used as the best predictor for the HBeAg seroconversion rate after the 48th week therapy in both groups.The HBeAg decreased more than 2log from the baseline to the 12th week can be used as the best pre-dictor for the HBeAg seroconversion rate after the 48th week therapy in the peginterferonα-2a group,and the HBeAg decreased more than 2log from the baseline to the 36th week can be used as the best predictor for the HBeAg seroconversion rate after the 48th week therapy in the TLD group.
-
Keywords:
- hepatitis virus /
- hepatitis B /
- hepatitis E antigen /
- peginterferonα-2a /
- tel-bivudine
-
-
期刊类型引用(2)
1. 章明阳，刘京辉，金雁，徐文琪，李斌飞，黄珊，杜李百合，侯亚甜，李小寒. 围手术期低体温风险预测模型的系统评价. 护理学报. 2024(22): 54-60 . 
百度学术
2. 丁旭，曹霞，王鹰，陈雷. 优化术中管理对老年骨科手术患者住院期间发生下肢深静脉血栓的预防作用. 血管与腔内血管外科杂志. 2024(12): 1511-1514+1528 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 282
- HTML全文浏览量: 46
- PDF下载量: 0
- 被引次数: 2
下载:
苏公网安备 32100302010246号
